1 min read
Senti Biosciences Board Approves 1-for-33 Reverse Stock Split
The company announced the board’s decision Nov. 17.

Senti Biosciences Holdings, Inc. (SNTI) announced Nov. 17 that its board determined to effect a 1-for-33 reverse split of its common stock, combining 33 shares into one.
The common stock has a par value of $0.0001 per share.